Potent immune responses of Ag-specific Vγ2Vδ2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans

AIDS

Volumn 22, Issue 17, 2008, Pages 2241-2250

  Shao, Lingyun ^a,b   Zhang, Wenhong ^a,b   Zhang, Shu ^a   Chen, Crystal Y ^b   Jiang, Weimin ^a   Xu, Yunya ^c   Meng, Chengyan ^a   Weng, Xinhua ^a   Chen, Zheng W ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

^c Department of Infectious Diseases   (China)

Author keywords

HIV AIDS; Latent TB; T cell based enzyme linked immunospot assay for tuberculosis; Tuberculosis; V 2V 2+ T cells

Indexed keywords

GAMMA INTERFERON; PYROPHOSPHATE; TUBERCULIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BCG VACCINATION; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 56549116533     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283117f18     Document Type: Article

References (27)

1. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545-550.
2. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol 2005; 5:819-826.
3. Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun 2001; 69:4195-4201.
4. Ormerod LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull 2005; 73-74:17-24.
5. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001; 193:271-280.
6. Chen ZW. Immunology of AIDS virus and mycobacterial co-infection. Curr HIV Res 2004; 2:351-355.
7. Lewinsohn DM, Alderson MR, Briden AL, Riddell SR, Reed SG, Grabstein KH. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med 1998; 187:1633-1640.
8. Woodworth JS, Behar SM. Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. Crit Rev Immunol 2006; 26:317-352.
9. van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000; 30:3689-3698.
10. Rojas RE, Chervenak KA, Thomas J, Morrow J, Nshuti L, Zalwango S, et al. Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay. J Infect Dis 2005; 192:1806-1814.
11. Gioia C, Agrati C, Casetti R, Cairo C, Borsellino G, Battistini L, et al. Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol 2002; 168:1484-1489.
12. Dieli F, Sireci G, Caccamo N, Di Sano C, Titone L, Romano A, et al. Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis. J Infect Dis 2002; 186:1835-1839.
13. Chen ZW. Immune regulation of gammadelta T cell responses in mycobacterial infections. Clin Immunol 2005; 116:202-207.
14. Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L, et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 2002; 295:2255-2258.
15. Chen ZW, Kou ZC, Lekutis C, Shen L, Zhou D, Halloran M, et al. T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J Exp Med 1995; 182:21-31.
16. Shen Y, Shen L, Sehgal P, Huang D, Qiu L, Du G, et al. Clinical latency and reactivation of AIDS-related mycobacterial infections. J Virol 2004; 78:14023-14032.
17. Chen Y, Shao L, Ali Z, Cai J, Chen ZW. NSOM/QD-based nanoscale immune-fluorescence imaging of antigen-specific T cell receptor responses during an in vivo clonal V{gamma}2V {delta}2 T cell expansion. Blood 2007; 111:4220-4232.
18. Ali Z, Shao L, Halliday L, Armin Reichenberg A, Hintz M, Jomaa H, Chen ZW. Prolonged HMBPP-driven antimicrobial and cytotoxic responses of mucosal and systemic Vγ2Vδ2 T-cells in macaques. J Immunol 2007; 179:8287-8296.
19. Chen ZW, Letvin NL. Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm. Trends Immunol 2003; 24:213-219.
20. Huang D, Shen Y, Qiu L, Chen CY, Shen L, Estep J, et al. Immune distribution and localization of phosphoantigen-specific V{gamma}2V{delta}2 T cells in lymphoid and nonlymphoid tissues in M. tuberculosis infection. Infect Immun 2007; 76:426-436.
21. Shen L, Shen Y, Huang D, Qiu L, Sehgal P, Du GZ, et al. Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells. J Infect Dis 2004; 190:1438-1447.
22. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gated JM, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 2002; 288:222-235.
23. Wang H, Lee HK, Bukowski JF, Li H, Mariuzza RA, Chen ZW, et al. Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells. J Immunol 2003; 170:3696-3706.
24. Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368:2142-2154.
25. Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobongwana M, et al. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 2007; 7:99.
26. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175:514-520.
27. Rangaka MX, Diwakar L, Seldon R, van Cutsem G, Meintjes GA, Morroni C, et al. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis 2007; 44:1639-1646.